Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, 14176 Tehran, Iran.
School of Chemistry, University College of Science, University of Tehran, PO Box 14155-6455, Tehran, Iran.
Bioorg Chem. 2019 Sep;90:103055. doi: 10.1016/j.bioorg.2019.103055. Epub 2019 Jun 10.
Structure activity correlation revealed that the quinoxaline ring is a satisfactory backbone for anticancer activity and a specific functional group at position 1 and 2 can improve the activity. In this basis, besides quinoxaline, imidazoles as potential anticancer agents were used as a supplementary agents for cancer treatment. In this paper, a new series of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives were synthesized in a simple and efficient step. The products are fully characterized by 1H NMR, C NMR, FT-IR, HRMS, and CHN elemental analysis. Several starting materials with different functionalities have been used for the synthesis of the final products with high isolated yields. The biological activities of the synthesized compounds were evaluated in kinase inhibition and cytotoxic activity in several cancerous cell lines. All compounds (6) were evaluated for inhibition of the cell proliferation using 4 cancerous cell lines. Five of the more active compounds were studied for determination of IC50 Compounds 6(32-34) showed good activity on some of cancerous cell lines. The results showed that compound 6-32 has the highest biological activity (IC% 9.77 for K562 cell line). An IC% value of 15.84 µM was observed for 6-34. Furthermore 6-34 exhibited inhibition of ABL1 and c-Src kinases with an IC50% value of 5.25 µM and 3.94 µM respectively. Docking simulation was performed to position active synthesized compounds 6-32, 6-33, and 6-34 over the ABL1 active site in two different wild-type (DFG-in and DFG-out motif conformer) and T315I mutant to determine the probable binding orientation, conformation and mode of interaction. According to docking study, the docked location in wild type forms is similar and can be found near the P-loop region while in the case of T315I mutant form, the compounds have a distinct docked location which is close to the αC helix and activation loop. Also, it concluded the role of R substituent on phenyl ring produced higher interaction energy. Additionally, the detailed inter-molecular energy and types of non-bonding interaction of these compounds over the wild-type and mutant form of ABL1.
构效关系研究表明,喹喔啉环是具有抗癌活性的理想骨架,在 1 位和 2 位引入特定的官能团可以提高活性。在此基础上,除了喹喔啉,咪唑类也被用作抗癌药物的辅助剂来治疗癌症。在本文中,我们设计并合成了一系列新型的 N-烷基-2,4-二苯基咪唑并[1,2-a]喹喔啉-1-胺衍生物。通过 1H NMR、C NMR、FT-IR、HRMS 和 CHN 元素分析对产物进行了全面的表征。我们使用了不同功能的几种起始原料,以高产率合成了最终产物。我们对合成化合物的激酶抑制活性和在几种癌细胞系中的细胞毒性进行了评价。所有化合物(6)都用于抑制 4 种癌细胞系的细胞增殖。对 5 种活性较高的化合物进行了 IC50 值的测定。化合物 6-32、6-33 和 6-34 对 K562 细胞系的活性最高(IC%为 9.77)。化合物 6-34 的 IC50 值为 15.84µM。此外,化合物 6-34 对 ABL1 和 c-Src 激酶的抑制活性的 IC50 值分别为 5.25µM 和 3.94µM。我们进行了 docking 模拟,以确定活性合成化合物 6-32、6-33 和 6-34 在 ABL1 活性位点上的可能结合取向、构象和相互作用模式。根据对接研究,野生型构象的对接位置相似,可在 P 环区域附近找到,而在 T315I 突变体中,化合物的对接位置明显靠近 αC 螺旋和激活环。此外,它还确定了苯环上 R 取代基的作用产生了更高的相互作用能。此外,还研究了这些化合物在 ABL1 野生型和突变型中的详细分子间能量和非键相互作用类型。